Kidney stones: symptoms, diagnosis and management

Kidney stones are a source of significant patient morbidity. Pharmacists can have an impact in identifying, triaging and supporting patients with the management of this condition.
Woman feeling mid-side back ache due to kidney stones

After reading this article you should be able to:

  • Identify patients that may be more likely to develop kidney stones;
  • Recognise the presenting symptoms of kidney stones and understand how to take an appropriate history to aid diagnosis;
  • Manage patients with kidney stones, including referral and provision of advice relating to future prevention.

Introduction

Kidney stones, or renal calculi, are hard deposits made of minerals and salts that form inside the kidneys​1​. They originate in the kidneys but can be found at any point in the urinary tract​1–3​. The stone may block urinary flow and pain arises from the obstruction of the kidneys collecting system (causing renal colic) or the ureter (causing uretic colic) as it attempts to pass out of the body​1–3​.

Many people may not experience symptoms; in 2010, results from one population study (n= 5,047) demonstrated an asymptomatic prevalence of 8%​4​. Acute presentations have an annual incidence of  one to two cases per 1,000 people in the UK; it is estimated that 12% of men and 6% of women will have one episode of associated colic at some stage during their life​5​. Although preventable, more than half of those diagnosed with kidney stones will develop another within five to ten years​6​.

Peak age incidence for men is 40–60 years — two-thirds of whom are likely to have recurrent stones — and the peak age incidence is late 20s for women​5​. Hormonal differences, such as the protective effect of oestrogen, as well as a gender difference seen in urinary pH, calcium excretion and metabolic disorder prevalence, are thought to contribute to the lower incidence in females​7​.

Around 80% of kidney stones can be passed spontaneously without intervention; however, depending on the size of stone and patient factors (e.g. the anatomy of the patient), medication or surgical interventions may be required​5,8​

Global incidence of kidney stones is increasing​9​. This increasing prevalence and potential for prevention of stones in working age adults makes this an area in which pharmacists can have an impact in identifying, triaging and supporting patients​10,11​.

Causes and pathophysiology 

The exact pathophysiology of stone formation is still debated; however, it is thought to be a heterogeneous process​1​. Stones are more likely to form when the urine is concentrated and there is an excess of waste products, such as minerals, which crystallise, nucleate and grow to form stones​1​.

Composition of the stone may allow for causes and risk factors to be identified; see Table​1,2,8,12​.

Risk factors

Some patients will be more at risk of kidney stones; non-modifiable risk factors include:

  • Male sex: the incidence is 2.5:1 male to female, but this gap looks to be narrowing​10,13​;
  • White ethnicity: in 1994, US study data showed the highest prevalence in white men followed by Hispanic, Asian and Black men​14​
  • Family history: those with a family history of kidney stones are more likely to develop multiple stones and experience early recurrence​1​
  • Medical history: several conditions increase the risk of stone formation, including anatomical abnormalities of the kidney or urinary tract, genetic conditions affecting metabolism (e.g. adenine phosphoribosyltransferase [APRT] deficiency, cystinuria, Dent disease), gastro-intestinal conditions affecting absorption (e.g. inflammatory bowel disease), conditions that alter urinary pH (e.g. chronic nephritis, gout), volume or concentration​3,8,11,15–17​.

There is some evidence that occupational exposure to heat increases risk, although evidence is weaker in this area​5​. Occupational exposure to cadmium and lead is associated with stone formation​5​. Prevalence of kidney stones also increases with increasing weight/BMI​14​.

Signs and symptoms 

Although some patients will be asymptomatic, patients with larger stones are likely to experience renal or ureteric colic pain and present to a healthcare professional for assistance in a community pharmacy, GP or acute care setting. 

Pain is severe, intense and abrupt in onset; it is unilateral, originating in the loin or flank radiating down to the groin/testicles in men or labia in women, see Figure​8​. Pain is caused by increased intraluminal pressure stretching the nerve endings of the collecting system or ureter​1​. Other contributors to pain may include local inflammatory mediators, hyperperistalsis (i.e. excessive or excessively vigorous peristalsis of ureters), mucosal irritation and oedema​1​

Illustration showing a darker swell of pain on the front of the left rib cage through to the back, and a lighter swell of pain from just below that to the top of the left thigh.
Figure: Pain location in kidney stones patients

Wes Mountain/The Pharmaceutical Journal

Pain occurs in spasms (with intervals of dull ache or no pain) that can last anywhere between minutes to hours​1,8​. A patient may describe it as the worst pain that they have ever experienced. At its most severe, the pain may be accompanied by nausea and vomiting. A standard scoring system can be used to monitor pain and the STONE score (online calculator can be found here) can be used to determine the risk of stone presence and prevent re-imaging in those with a previous history​18​

If the stone irritates the detrusor muscle or blocks the vesico-ureteric junction, patients may experience increased urinary frequency, pain on urination or straining​8​.

Patients will require immediate hospital admission if:

  • There are signs of systemic infection (e.g. fever or sweats) or sepsis; 
  • They have pre-existing conditions that increases risk of acute kidney injury (e.g. chronic kidney disease, transplanted kidney);
  • They are dehydrated and can no longer take oral fluids owing to nausea/vomiting​8​.

Diagnosis 

All patients with suspected renal colic should be referred urgently (within 24 hours) for non-contrast CT imaging to confirm diagnosis​3​. Ultrasound can be used as an alternative for pregnant women​8​. Blood tests (full blood count, urea and electrolytes) to confirm kidney function and potential precipitating conditions should be completed in tandem​1​

The CT scan will confirm the diagnosis, number, location and size of stones, as well as anatomical abnormalities associated with recurrent stones​8​. Women of childbearing age should have a pregnancy test to rule out ectopic pregnancy, which may have overlapping symptoms, such as pelvic pain and urinary symptoms​1​.

The location and the type of pain can help to distinguish kidney stones from other conditions, such as appendicitis, where the pain is in the right lower quadrant and is typically more persistent and accompanied by fever​1​. Patients with renal colic may be more restless and unable to lie still unlike the pain in peritonitis, which is an infection in the thin layer of tissue in the abdomen​8​.

There may be haematuria (blood in the urine) present on a urinary dipstick, which should be undertaken to rule out the diagnosis of a urinary tract infection or pyelonephritis​1,8​

Management

Supportive care

Patients with kidney stones will need assistance with pain relief. The National Institute for Health and Care Excellence recommends that a non-steroidal anti-inflammatory drug (NSAID) should be used as first-line treatment by any route​3​. However, renal function should be checked before prescribing an NSAID as some patients may develop acute kidney injury from the stone and NSAIDs are contraindicated in renal failure​19​. Intravenous paracetamol can be used if NSAIDs are contraindicated or do not offer sufficient relief, with opiates being a third-line option​3​. Anti-emetics can assist with nausea​1​. Antibiotics should be given if urinary cultures are positive​1​.

Stone removal

Symptoms, size and placement of stones determine the management route taken to remove the stone:

  • Asymptomatic stones less than 5mm: watchful waiting employed as spontaneous stone passage is more likely with smaller stones​11​;
  • Asymptomatic stones larger than 5mm: watchful waiting with patient agreement as to risks and benefits​8​. These stones should not affect quality of life if the patient has limited symptoms and may not need intervention, but there is the risk of location change and obstruction, bleeding and the development of symptoms​3​;
  • Symptomatic stones less than 10mm: may benefit from medical expulsive therapy, which is where a medication is used to help patients pass the stone spontaneously. Alpha blockers are used for this indication (unlicensed [e.g. Tamsulosin]), with 400 micrograms daily until stone expulsion​20​. Inhibition of smooth muscle contraction in the ureter assists the passage of the stone into the bladder​21​.

Stones unlikely to pass, where the pain is ongoing (48 hours) or not tolerated, may be candidates for a procedure for removal​3​. The choice of procedure is based on anatomy, stone size and patient factors:

  • Shockwave lithotripsy: uses shock waves to break up the stone into easier to pass fragments​8​
  • Percutaneous nephrolithotomy: endoscopy of kidney during which the stone is broken down by instruments or lasers and removed​2​;
  • Ureteroscopy: endoscopy of the ureter with instruments or energy waves for break down the stone for removal​8​;
  • Open surgery: rarely used, but remains an option for when the above procedures fail or are unlikely to be successful​11​.

Once passed, the stone can be sent for analysis to determine composition; this can help tailor future prevention advice to the patient​10​.

Advice on prevention

Given the high risk of reoccurrence, pharmacists can have a role in counselling patients on lifestyle modifications to reduce risk of new stone formation. The BMJ has produced an article on dietary management that may be useful when stone analysis has been performed to tailor the advice to the patient based on the stone composition​10​. Despite calcium being the most prevalent element found in kidney stones, restriction of dietary calcium actually adversely affects stone reoccurrence​10​. For patients unsure of their usual calcium intake, the online chart by the Bone Health and Osteoporosis Foundation can be used​22​.

If lifestyle advise fails, patients with recurrent stones that are predominantly (more than 50%) calcium oxalate may benefit from potassium citrate or thiazide treatment​2​. Patients taking medications that can induce kidney stone formation should have their use reviewed, considering the patient holistically and whether any metabolic or dietary factors have since resolved. Lifestyle adjustments may prevent reoccurrence, and drug removal may not be required​23​.

General prevention advice for patients is shown in the Box below​8,10,11​.

Box: Summary of guidance on preventing kidney stones

Fluid intake advice:

  • 2.5–3.0L of water a day for adults, and 1–2L a day for children, depending on age;
  • Water is the preferred fluid for drinking;
  • Avoid carbonated drinks and calorie-containing fluids;
  • Reduce alcohol intake;
  • Add lemon juice to water (citrate may inhibit stone formation)
  • Address any fluid losses (e.g. sweating in hot climates or vomiting) with additional fluid intake.

Nutritional advice:

  • Limit salt intake to no more than 6 grams, and for children and young people (depending on their age), 2–6 grams a day. Excess sodium intake leads to an increased urinary calcium concentration and reduced urinary citrate, promoting calcium crystallisation;
  • Do not restrict dietary calcium and aim for a calcium intake of 700–1,200mg a day, and for children and young people (depending on their age), 350–1,000 mg a day;
  • Reduce protein from animal sources; diets rich in meat protein affects urinary citrate, oxalate and calcium levels to increase risk of stone formation;
  • Eat fruits and vegetables that are high in fibre.

Complications

Suspected kidney stones should not be ignored. Complications include obstruction of urinary flow and infection; persisting obstruction reduces renal blood flow and may cause kidney damage and chronic kidney disease​1,8,11,24,25​. Presence of kidney stones is also associated with coronary heart disease, stroke and renal cancer​26,27​.


Patient case study

A 48-year-old male (95kg) presents to the community pharmacy after experiencing back pain for two days that comes on at night and lasts for approximately four hours. Paracetamol has been tried but did not provide any relief.

The pharmacist asks the patient the following questions:

  • Where is the location of the pain?
  • Is there any pain or change in urination?
  • Has there been any injury to the back or any strenuous activity?
  • Is the pain only at night?
  • Are there any other symptoms?

The patient reported pain in the upper back on the right-hand side only. They had not noticed any changes in urination but admitted their urine was generally on the darker side. They had not experienced any injuries or completed any activities that could have resulted in muscle damage. They felt some slight throbbing during the day, but the pain at night was the worst thing they have ever experienced and they were vomiting as they were in so much pain. Vomiting did not relieve the pain.

Based on the further description of the patient, the pharmacist recommended that they seek an urgent medical appointment as they may need a referral for a potential kidney stone.

The patient saw their GP that day, was referred to accident and emergency with a letter for an urgent CT. The CT scan showed a small luminous mass of 4mm in the right kidney consistent with kidney stones. The patients GFR was 45mL/minute. The patient was admitted overnight and received paracetamol and codeine for pain. Owing to stone size, they were discharged and told to drink two to three litres of water per day to promote removal, with a follow-up planned for further imaging in five days’ time.

The patient passed their stone three days after discharge from hospital. Further imaging confirmed absence of the stone. Advice was given on weight reduction and fluid management to prevent reoccurrence.

Best practice

  • All suspected symptomatic patients with kidney stones should be referred for examination;
  • Non-steroidal anti-inflammatory drugs are the first-line analgesic for renal colic if kidney function is unaffected;
  • All patients with kidney stones should be provided with lifestyle counselling to reduce risk of reoccurrence.

  1. 1.
    BMJ Best Practice. BMJ Best Practice. 2021. Accessed November 2024. http://www.bestpractice.bmj.com
  2. 2.
    Kidney stones. NHS. 2022. Accessed November 2024. https://www.nhs.uk/conditions/kidney-stones/
  3. 3.
    Renal and ureteric stones: assessment and management. National Institute for Health and Care Excellence. 2019. Accessed November 2024. https://www.nice.org.uk/guidance/ng118
  4. 4.
    Boyce CJ, Pickhardt PJ, Lawrence EM, Kim DH, Bruce RJ. Prevalence of Urolithiasis in Asymptomatic Adults: Objective Determination Using Low Dose Noncontrast Computerized Tomography. Journal of Urology. 2010;183(3):1017-1021. doi:10.1016/j.juro.2009.11.047
  5. 5.
    Occupational risks for urolithiasis: IIAC information note. Public Health England and Industrial Injuries Advisory Council. 2018. Accessed November 2024. https://www.gov.uk/government/publications/occupational-risks-for-urolithiasis-iiac-information-note/occupational-risks-for-urolithiasis-iiac-information-note
  6. 6.
    Uribarri J. The First Kidney Stone. Ann Intern Med. 1989;111(12):1006. doi:10.7326/0003-4819-111-12-1006
  7. 7.
    Gillams K, Juliebø-Jones P, Juliebø SØ, Somani BK. Gender Differences in Kidney Stone Disease (KSD): Findings from a Systematic Review. Curr Urol Rep. 2021;22(10). doi:10.1007/s11934-021-01066-6
  8. 8.
    Clinical Knowledge Summary: Renal or ureteric colic – acute. National Institute for Health and Care Excellence. 2020. Accessed November 2024. https://cks.nice.org.uk/topics/renal-or-ureteric-colic-acute
  9. 9.
    Lang J, Narendrula A, El-Zawahry A, Sindhwani P, Ekwenna O. Global Trends in Incidence and Burden of Urolithiasis from 1990 to 2019: An Analysis of Global Burden of Disease Study Data. European Urology Open Science. 2022;35:37-46. doi:10.1016/j.euros.2021.10.008
  10. 10.
    Morgan MSC, Pearle MS. Medical management of renal stones. BMJ. Published online March 14, 2016:i52. doi:10.1136/bmj.i52
  11. 11.
    Urolithiasis [Clinical Guideline]. European Association of Urology. 2024. Accessed November 2024. https://uroweb.org/guidelines/urolithiasis/chapter/guidelines
  12. 12.
    Kidney stones. British Association of Urological Surgeons. 2024. Accessed November 2024. https://www.baus.org.uk/patients/conditions/6/kidney_stones/
  13. 13.
    Stamatelou KK, Francis ME, Jones CA, Nyberg LM Jr, Curhan GC. Time trends in reported prevalence of kidney stones in the United States: 1976–199411.See Editorial by Goldfarb, p. 1951. Kidney International. 2003;63(5):1817-1823. doi:10.1046/j.1523-1755.2003.00917.x
  14. 14.
    Soucie JM, Thun MJ, Coates RJ, McClellan W, Austin H. Demographic and geographic variability of kidney stones in the United States. Kidney International. 1994;46(3):893-899. doi:10.1038/ki.1994.347
  15. 15.
    Morse JM. The PI as Participant. Qual Health Res. 2009;19(12):1655-1655. doi:10.1177/1049732309353421
  16. 16.
    Aune D, Mahamat-Saleh Y, Norat T, Riboli E. Body fatness, diabetes, physical activity and risk of kidney stones: a systematic review and meta-analysis of cohort studies. Eur J Epidemiol. 2018;33(11):1033-1047. doi:10.1007/s10654-018-0426-4
  17. 17.
    Edvardsson VO, Goldfarb DS, Lieske JC, et al. Hereditary causes of kidney stones and chronic kidney disease. Pediatr Nephrol. 2013;28(10):1923-1942. doi:10.1007/s00467-012-2329-z
  18. 18.
    STONE Score for Uncomplicated Ureteral Stone. MDCalc. 2024. Accessed November 2024. https://www.mdcalc.com/calc/10110/stone-score-uncomplicated-ureteral-stone
  19. 19.
    British National Formulary. British National Formulary. Accessed November 2024. https://bnf.nice.org.uk/
  20. 20.
  21. 21.
    Sun Y, Lei GL, Yang L, Wei Q, Wei X. Is tamsulosin effective for the passage of symptomatic ureteral stones. Medicine. 2019;98(10):e14796. doi:10.1097/md.0000000000014796
  22. 22.
    Steps to Estimate Your Calcium Intake. Bone Health and Osteoporosis Foundation. Accessed November 2024. https://www.bonehealthandosteoporosis.org/patients/treatment/calciumvitamin-d/steps-to-estimate-your-calcium-intake/
  23. 23.
    Matlaga B, Shah O, Assimos D. Drug-induced urinary calculi. Rev Urol. 2003;5(4):227-231. https://www.ncbi.nlm.nih.gov/pubmed/16985842
  24. 24.
    Managing patients with renal colic in primary care: know when to hold them. Best Practice Advocacy Centre New Zealand. 2014. Accessed November 2024. https://bpac.org.nz/bpj/2014/april/colic.aspx
  25. 25.
    Shang W, Li L, Ren Y, et al. History of kidney stones and risk of chronic kidney disease: a meta-analysis. PeerJ. 2017;5:e2907. doi:10.7717/peerj.2907
  26. 26.
    Gambaro A, Lombardi G, Caletti C, Ribichini FL, Ferraro PM, Gambaro G. Nephrolithiasis: A Red Flag for Cardiovascular Risk. JCM. 2022;11(19):5512. doi:10.3390/jcm11195512
  27. 27.
    Peng JP, Zheng H. Kidney stones may increase the risk of coronary heart disease and stroke. Medicine. 2017;96(34):e7898. doi:10.1097/md.0000000000007898
Last updated
Citation
The Pharmaceutical Journal, PJ, November 2024, Vol 313, No 7991;313(7991)::DOI:10.1211/PJ.2024.1.336734

    Please leave a comment 

    You might also be interested in…